Inhibitory effects of nardostachin on nitric oxide, prostaglandin E 2, and tumor necrosis factor-α production in lipopolysaccharide activated macrophages

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 10, 2003, Pages 1375-1378

  Ju, Hye Kyung ^a   Baek, Suk Hwan ^b   An, Ren Bo ^c   Bae, KiHwan ^c   Son, Kun Ho ^d   Kim, Hyun Pyo ^e   Kang, Sam Sik ^f   Lee, Sung Ho ^a   Son, Jong Keun ^a   Chang, Hyeun Wook ^a  

^a Yeungnam University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

^d Andong National University   (South Korea)

^e Kangwon National University   (South Korea)

^f Seoul National University   (South Korea)

Author keywords

Cyclooxygenase 2; Nardostachin; Niric oxide; Patrinia saniculaefolia; Prostaglandin E2; TNF

Indexed keywords

AUTACOID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; IRIDOID; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NARDOSTACHIN; NITRIC OXIDE; POLYCLONAL ANTIBODY; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DITERPENE; ISOENZYME; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PLANT EXTRACT; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG SCREENING; EXAMINATION; IC 50; INFLAMMATION; MACROPHAGE ACTIVATION; MEDICINAL PLANT; MOLECULAR PROBE; MOUSE; NONHUMAN; PATRINIA; PATRINIA SANICULAEFOLIA; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; MACROPHAGE; METABOLISM; PLANT;

ANIMALS; CYCLOOXYGENASE 2; DINOPROSTONE; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PATRINIA; PLANT COMPONENTS; PLANT EXTRACTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542751613     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.1375     Document Type: Article

References (26)

1. Ishiguro K., Yamaki M., Takagi S., J. Nat. Prod., 46, 532-536 (1983).
2. Ishiguro K., Yamaki M., Takagi S., Ikeda Y., Kawakami K., Ito K., Nose T., Pharmacobiodyn., 11, 131-136 (1988).
3. Circosta C., Occhiuto F., Ragusa S., Trovato A., Tumino G., Briguglio F., de Pasquale A., J. Ethnopharmacol., 11, 259-274 (1984).
4. Recio M. C., Giner R. M., Manez S., Rios J. L., Planta Med., 60, 232-234 (1994).
5. Diaz A. M., Abad M. J., Fernandez L., Recuero C., Villaescusa L., Silvan A. M., Bermejo P., Biol. Pharm. Bull., 23, 1307-1313 (2000).
6. Suksamrarn A., Kumpun S., Kirtikara K., Yingyongnarongkul B., Suksamrarn S., Planta Med., 68, 72-73 (2002).
7. Delaporte R., Sanchez G., Cuellar A., Giuliani A., Palazzo de Mello J., Ethnopharmacol., 82, 127-130 (2002).
8. Lee T. B., "Illstrated Flora of Korea," Hyangmoon Publ. Co., Seoul, 1980, p. 714.
9. Bagchi A., Oshima Y., Hikino H., Planta Med., 54, 87-88 (1988).
10. Ialenti A., Ianaro A., Moncada S., Di Rosa M., Eur. J. Pharmacol., 211, 177-182 (1992).
11. Weinstein S. L., Gold M. R., DeFranco A. L., Proc. Natl. Acad. Sci. U.S.A., 88, 4148-4152 (1991).
12. Raetz C. R., J. Bacteriol., 175, 5745-5753 (1993).
13. Drapier J. C., Wietzerbin J., Hibbs J. B., Jr., Eur. J. Immunol., 18, 1587-1592 (1988).
14. Lorsbach R. B., Murphy W. J., Lowenstein C. J., Snyder S. H., Russell S. W., J. Biol. Chem., 268, 1908-1913 (1993).
15. An R. B., Min B. S., An M. K., Chang H. W., Son K. H., Kim H. P., Kang S. S., Bae K. H., Chem. Pharm. Bull., 51, 583-585 (2003).
16. Mannel D. N., Echtenacher B., Chem. Immunol., 74, 141-161 (2000).
17. Glauser M. P., Drugs, 52, 9-17 (1996).
18. Marks J. D., Marks C. B., Luce J. M., Montgomery A. B., Turner J., Metz C. A., Murray J. F., Am. Rev. Respir. Dis., 141, 94-97 (1990).
19. Cannon J. G., Tompkins R. G., Gelfand J. A., Michie H. R., Stanford G. G., van der Meer J. W., Endres S., Lonnemann G., Corsetti J., Chernow B., J. Infect. Dis., 161, 79-84 (1990).
20. An S. J., Pae H. O., Oh G. S., Choi B. M., Jeong S., Jang S. I., Oh H., Kwon T. O., Song C. E., Chung H. T., Int. Immunopharmacol., 2, 1173-1181 (2002).
21. Oh H., Pae H. O., Oh G. S., Lee S. Y., Chai K. Y., Song C. E., Kwon T. O., Chung H. T., Lee H. S., Planta Med., 68, 685-689 (2002).
22. Tetsuka T., Daphna-Iken D., Miller B. W., Guan Z., Baier L. D., Morrison A. R., J. Clin. Invest., 97, 2051-2056 (1996).
23. Salvemini D., Manning P. T., Zweifel B. S., Seibert K., Connor J., Currie M. G., Needleman P., Masferrer J. L., J. Clin. Invest., 96, 301-308 (1995).
24. Goodwin D. C., Landino L. M., Marnett L. J., Drug Metab. Rev., 31, 273-294 (1999).
25. Goodwin D. C., Landino L. M., Marnett L. J., FASEB J., 13, 1121-1136 (1999).
26. Von Knethen A., Brune B., FASEB J., 11, 887-895 (1997).